Clinical data | |
---|---|
Trade names | GS-6620 |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C29H37N6O9P |
Molar mass | 644.622 g·mol−1 |
3D model ( JSmol) | |
| |
|
GS-6620 is an antiviral drug which is a nucleotide analogue. It was developed for the treatment of Hepatitis C but while it showed potent antiviral effects in early testing, [1] [2] it could not be successfully formulated into an oral dosage form due to low and variable absorption in the intestines which made blood levels unpredictable. [3] [4] It has however continued to be researched as a potential treatment for other viral diseases such as Ebola virus disease. [5] [6]